Hermetica Superfood Encyclopedia
The Short Answer
Uvaria chamae contains phenolics (177.6 mg/100g in root), flavonoids (165.9 mg/100g), alkaloids, tannins, saponins, and glycosides that exert DPPH free-radical scavenging, antimicrobial, and organ-protective effects through antioxidant and membrane-disrupting mechanisms. In rat models of CCl4-induced toxicity, oral stem extracts at 200–600 mg/kg body weight significantly reduced serum creatinine, urea, cardiac troponin I, LDL cholesterol, and LDH in a dose-dependent manner comparable to vitamin C at 20 mg/kg (p<0.05), though no human clinical trials have been conducted.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordUvaria chamae benefits
Uvaria chamae — botanical close-up
Health Benefits
**Antimicrobial Activity**
Leaf fractions demonstrate minimum inhibitory concentrations (MIC) of 37 µg/mL to 1.67 mg/mL and minimum bactericidal concentrations (MBC) of 0.037–2.5 mg/mL against foodborne pathogens including Pseudomonas aeruginosa, attributed to the membrane-disrupting and oxidative-stress-inducing properties of alkaloids, tannins, and phenolic acids.
**Antioxidant Protection**
Hydroethanolic leaf fractions show DPPH radical scavenging with IC50 values of 280 µg/mL (butanol fraction) and 379 µg/mL (ethyl acetate fraction), with activity correlating positively with total phenolic content and operating through hydrogen-atom donation and iron chelation mechanisms.
**Nephroprotective Effects**
Aqueous and ethyl acetate stem extracts at 200–600 mg/kg significantly lowered serum urea, creatinine, uric acid, sodium, potassium, and bicarbonate in CCl4-intoxicated rats, suggesting protection of renal tubular function via attenuation of oxidative damage to kidney tissue.
**Cardioprotective Effects**
The same stem extract doses significantly reduced cardiac troponin I (cTnI), creatine kinase (CK), lactate dehydrogenase (LDH), total cholesterol, triglycerides, and LDL in rat models, indicating mitigation of myocardial cell injury and lipid peroxidation-linked atherogenic risk.
**Hepatoprotective Activity**
Uvaria chamae is an ingredient in Ruzu herbal bitters, a commercial West African polyherbal formulation clinically and preclinically studied for hepatoprotective, antihyperlipidemic, and antidiabetic properties, with the phenolic and flavonoid content implicated in reducing hepatic oxidative stress markers.
**Anti-inflammatory Potential**: The rich tannin content (154
1 mg/100g in root extract) contributes to astringent and anti-inflammatory properties through inhibition of pro-inflammatory enzyme activity and protein precipitation, consistent with its traditional use in treating inflammatory conditions in Yoruba and Burkinabe ethnomedicine.
**Antidiabetic and Antihyperlipidemic Support**
Phytochemical constituents including saponins and flavonoids are associated with glucose uptake modulation and lipid-lowering effects in preclinical contexts, forming the pharmacological basis for the plant's inclusion in traditional formulations targeting metabolic disorders across West Africa.
Origin & History
Natural habitat
Uvaria chamae is a scrambling shrub native to tropical West and Central Africa, distributed across countries including Nigeria, Burkina Faso, Ghana, Senegal, and Cameroon, where it grows in forest margins, savanna woodlands, and secondary vegetation up to 1,500 meters elevation. It belongs to the Annonaceae family and thrives in well-drained sandy-loam soils under humid tropical conditions, often colonizing disturbed habitats and forest edges. The plant is gathered primarily from the wild for both food and medicinal use, with roots, stems, leaves, and fruits all utilized across various West African ethnobotanical traditions, particularly within Yoruba herbalism in southwestern Nigeria.
“Uvaria chamae holds an established place in the ethnobotanical traditions of the Yoruba people of southwestern Nigeria, where it is known by local names and incorporated into herbal formulations used by traditional healers (babalawos) for treating infections, fevers, and metabolic complaints. In Burkina Faso and other Sahelian and sub-Sahelian nations, the plant is consumed as both a food source and medicinal remedy, with its roots, leaves, and fruits integrated into daily therapeutic practices for conditions including kidney disorders, heart complaints, and skin infections. The plant is a recognized ingredient in Ruzu herbal bitters, a contemporary West African commercial herbal product blending traditional knowledge with partially modernized production, reflecting the transition of indigenous plant knowledge into semi-formalized herbal medicine markets. Documentation of specific traditional preparation recipes and dosing protocols in historical texts remains sparse, with most ethnobotanical knowledge transmitted orally across generations and compiled only recently in peer-reviewed ethnopharmacological surveys.”Traditional Medicine
Scientific Research
The scientific evidence base for Uvaria chamae consists entirely of preclinical in vitro and animal studies, with no published human clinical trials identified as of 2024, placing it at a preliminary evidence tier. Key studies include CCl4-induced toxicity models in Wistar rats (n=5 per group) examining nephro- and cardioprotective endpoints with oral stem extracts at 200–600 mg/kg, and in vitro antimicrobial assays (MIC/MBC broth microdilution) and DPPH radical scavenging assays performed on fractionated leaf hydroethanolic extracts. Phytochemical quantification studies have characterized root extract composition with reasonable analytical precision (e.g., phenolics 177.6 ± 0.75 mg/100g, flavonoids 165.9 ± 0.61 mg/100g), lending credibility to the presence of bioactive compounds, though neither standardization nor bioavailability data in humans exist. The overall body of evidence is limited by small animal group sizes, absence of dose-response modeling beyond three dose points, lack of pharmacokinetic data, and complete absence of randomized controlled trial data, meaning results cannot be extrapolated to human therapeutic use without further investigation.
Preparation & Dosage
Traditional preparation
**Crude Root Aqueous Decoction (Traditional)**
50–100 mL) taken one to three times daily
Roots are boiled in water and consumed as a decoction; no standardized dose exists, but traditional use in West Africa involves small volumes (approximately .
**Hydroethanolic Leaf Extract (Research Form)**
67 mg/mL for antimicrobial testing
Prepared by macerating dried leaves in 70–80% ethanol/water, then fractionating sequentially into hexane, dichloromethane, ethyl acetate, and butanol fractions; used in in vitro assays at concentrations of 37 µg/mL to 1..
**Aqueous and Ethyl Acetate Stem Extracts (Preclinical Oral Dosing)**
200 mg/kg, 400 mg/kg, and 600 mg/kg body weight orally; allometric scaling to a 70 kg human (using a factor of ~6
Administered to rats at .2) would suggest rough human-equivalent doses of approximately 2,258–6,774 mg/day, though this extrapolation is speculative and not validated.
**Polyherbal Formulation (Ruzu Herbal Bitters)**
Commercially available liquid formulation containing Uvaria chamae alongside other herbs; dosing follows manufacturer or prescriber guidelines and no standardization for Uvaria chamae content is disclosed.
**Standardization Status**
No standardized extract specifying percentage of total phenolics, flavonoids, or alkaloids is commercially available; phytochemical variability across plant parts and geographic origins precludes consistent dosing without validated standardization protocols.
**Timing**
No clinical data exist to inform optimal timing of administration; traditional use does not specify meal-related timing.
Nutritional Profile
The root of Uvaria chamae contains crude protein (2.65 ± 0.01%) and carbohydrates (42.72 ± 0.01%) as primary macronutrients, suggesting limited direct nutritional contribution as a protein or energy source at typical medicinal doses. Phytochemical concentrations in the root are significant: phenolics (177.6 ± 0.75 mg/100g), flavonoids (165.9 ± 0.61 mg/100g), tannins (154.1 ± 1.73 mg/100g), alkaloids (107.2 ± 0.55 mg/100g), saponins (77.57 ± 1.19 mg/100g), and glycosides (10.16 ± 0.01 mg/100g). In other plant parts (leaves, stems, bark), flavonoids range 0.70–5.70 mg/100g, alkaloids 0.81–5.40 mg/100g, tannins 0.40–3.60 mg/100g, saponins 0.38–2.10 mg/100g, and phenols 0.08–0.10 mg/100g, indicating the root is the most phytochemically concentrated part. Bioavailability of these compounds in humans is unknown; the polarity-dependent fractionation data (butanol > ethyl acetate > dichloromethane > hexane for antioxidant activity) suggests that polar phenolics and flavonoids are the most bioactive fractions, consistent with generally higher intestinal absorption of hydrophilic polyphenols, though first-pass metabolism and gut microbiome transformation have not been studied for this species.
How It Works
Mechanism of Action
The antioxidant mechanism of Uvaria chamae operates primarily through hydrogen-atom transfer and single-electron transfer pathways, with phenolic hydroxyl groups and flavonoid B-ring catechol units donating electrons to neutralize reactive oxygen species including DPPH radicals, superoxide anion, and hydroxyl radicals; this correlates quantitatively with total phenolic content across fractions. Antimicrobial activity is mediated by membrane disruption, where alkaloids intercalate into bacterial phospholipid bilayers causing leakage of intracellular contents, while tannins precipitate microbial surface proteins and chelate metal cofactors essential for bacterial enzyme function, collectively lowering MIC values to 37 µg/mL in the most active fractions. Organ-protective effects involve suppression of lipid peroxidation cascades initiated by CCl4-derived trichloromethyl radicals, with saponins and polyphenols upregulating endogenous antioxidant defenses including superoxide dismutase and catalase activity, thereby preventing oxidative damage to renal tubular epithelium and cardiomyocyte membranes as reflected by normalized serum cTnI, CK, and LDH levels. Specific receptor-binding interactions, gene expression targets, and enzyme inhibition kinetics (such as IC50 values against cyclooxygenase or xanthine oxidase) have not yet been characterized at the molecular level in peer-reviewed studies, representing a significant gap in mechanistic understanding.
Clinical Evidence
No human clinical trials have investigated Uvaria chamae as a standalone intervention, and all efficacy data derive from preclinical rodent experiments and in vitro bioassays. The most structured preclinical data come from CCl4-model rat studies demonstrating dose-dependent reductions in renal function markers (urea, creatinine, uric acid) and cardiac injury markers (cTnI, CK, LDH, LDL) at 200–600 mg/kg oral stem extract, with outcomes reaching statistical significance (p<0.05) and showing comparability to the positive control vitamin C at 20 mg/kg, though effect sizes and confidence intervals were not reported. Uvaria chamae is an acknowledged constituent of Ruzu herbal bitters, which has undergone some clinical investigation for antihyperlipidemic and antidiabetic effects, but attribution of outcomes specifically to Uvaria chamae within that polyherbal mixture is not possible from available data. Confidence in translating these preclinical findings to human therapeutic recommendations is very low, and rigorous Phase I safety trials followed by efficacy RCTs are needed before any clinical claims can be substantiated.
Safety & Interactions
No formal human safety studies, toxicological assessments, or pharmacovigilance data exist for Uvaria chamae, and all available safety information derives from preclinical rat studies that reported no observable adverse effects at doses up to 600 mg/kg body weight over the study duration, which represents a very limited safety dataset. The high tannin content (154.1 mg/100g in root) raises a theoretical concern for inhibition of iron and protein absorption if consumed in large quantities or alongside iron-rich meals, and saponins at elevated doses are associated with gastrointestinal irritation and hemolytic activity in some plant species, warranting caution. Potential additive or synergistic interactions with antibiotic drugs are plausible given demonstrated antimicrobial MIC values of 37 µg/mL against Pseudomonas aeruginosa, but no clinical interaction studies have been performed; interactions with anticoagulants, antidiabetic agents, or antihypertensive medications are theoretically possible given the plant's reported physiological effects but remain uninvestigated. Uvaria chamae should be avoided during pregnancy and lactation in the absence of safety data, and individuals with kidney or liver disease should consult a healthcare provider before use, as the plant's organ-modifying bioactivity could interact unpredictably with compromised organ function or pharmaceutical treatments.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Uvaria chamae P.Beauv.Bush bananaFinger root (West Africa)Ruzu herb componentAnnonaceae shrub West Africa
Frequently Asked Questions
What is Uvaria chamae used for in traditional African medicine?
Uvaria chamae is used in Yoruba and West African traditional medicine to treat infections, kidney complaints, heart conditions, fevers, and metabolic disorders including hyperlipidemia and diabetes. Its roots, leaves, stems, and fruits are all utilized, often prepared as water decoctions or hydroethanolic extracts, and it is an ingredient in Ruzu herbal bitters, a commercial West African polyherbal formulation. Traditional use spans Nigeria, Burkina Faso, Ghana, and neighboring countries, where it is recognized as both a food plant and a medicinal remedy.
Does Uvaria chamae have proven antimicrobial activity?
In vitro studies have demonstrated that fractionated leaf extracts of Uvaria chamae inhibit foodborne pathogens including Pseudomonas aeruginosa, with minimum inhibitory concentrations (MIC) ranging from 37 µg/mL to 1.67 mg/mL and minimum bactericidal concentrations (MBC) from 0.037 to 2.5 mg/mL. These effects are attributed to membrane-disrupting alkaloids and protein-precipitating tannins present in high concentrations in the root (alkaloids 107.2 mg/100g, tannins 154.1 mg/100g). However, no human clinical trials have validated these antimicrobial effects in vivo, so results should be interpreted as preliminary.
What are the main bioactive compounds found in Uvaria chamae?
The primary bioactive compounds in Uvaria chamae are phenolics, flavonoids, alkaloids, tannins, saponins, and glycosides, with concentrations varying by plant part. Root extracts contain the highest levels: phenolics (177.6 ± 0.75 mg/100g), flavonoids (165.9 ± 0.61 mg/100g), tannins (154.1 ± 1.73 mg/100g), alkaloids (107.2 ± 0.55 mg/100g), saponins (77.57 ± 1.19 mg/100g), and glycosides (10.16 ± 0.01 mg/100g). The butanol and ethyl acetate fractions of leaf hydroethanolic extracts show the highest antioxidant activity, correlating with their greater total phenolic content.
Is Uvaria chamae safe to consume, and are there any known side effects?
No human safety trials have been conducted on Uvaria chamae, so its safety profile in people is not established. Preclinical rat studies reported no adverse effects at oral doses up to 600 mg/kg body weight, but this limited data cannot be directly extrapolated to human use. The high tannin content may theoretically impair iron absorption, and saponins could cause gastrointestinal irritation at high doses; use during pregnancy or lactation and in individuals with kidney or liver disease is not recommended due to insufficient safety data.
What is the recommended dose of Uvaria chamae?
There is no established or standardized human dose for Uvaria chamae, as no clinical trials have determined a safe or effective human dosage. Preclinical rat studies used oral doses of 200–600 mg/kg body weight of stem extracts, which allometrically suggest rough human-equivalent doses of approximately 2,000–6,700 mg/day for a 70 kg adult, but this extrapolation is speculative and not clinically validated. Anyone considering use should consult a qualified healthcare practitioner, and dosing within commercially available polyherbal formulations like Ruzu herbal bitters should follow product labeling.
Does Uvaria chamae interact with common antibiotics or antimicrobial medications?
While Uvaria chamae demonstrates potent antimicrobial activity in laboratory studies with MICs ranging from 37 µg/mL to 1.67 mg/mL, there is limited clinical data on interactions with prescription antibiotics. The alkaloids and phenolic compounds in Uvaria chamae that disrupt bacterial membranes could theoretically potentiate or interfere with certain antimicrobial drugs, making concurrent use a consideration for medical supervision. More human clinical trials are needed to establish safe concurrent use with conventional antimicrobial therapies.
Is Uvaria chamae safe to use during pregnancy or while breastfeeding?
There is insufficient clinical safety data on Uvaria chamae use during pregnancy or lactation, and it is not recommended without professional medical guidance. Traditional use does not guarantee safety for vulnerable populations, and the alkaloid and tannin content warrants caution during these sensitive periods. Pregnant or breastfeeding individuals should consult a healthcare provider before considering Uvaria chamae supplementation.
What does current research show about Uvaria chamae's effectiveness compared to synthetic antimicrobial agents?
Laboratory studies demonstrate that Uvaria chamae leaf fractions achieve bactericidal concentrations (0.037–2.5 mg/mL) against foodborne pathogens like Pseudomonas aeruginosa through membrane disruption and oxidative stress mechanisms similar to some conventional antimicrobials. However, most evidence is limited to in vitro studies; human clinical trials directly comparing Uvaria chamae efficacy to pharmaceutical antimicrobials are lacking. The herb shows promise as a complementary approach, but more rigorous clinical research is needed to establish therapeutic equivalence.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w uvaria-chamae-uvaria-chamae-pbeauv curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
